B Cell Targeting in Idiopathic Thrombocytopenic Purpura
EurekAlert!
The New England Journal of Medicine has published a phase III clinical trial showing that a B cell targeting monoclon
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.